Post-Vaccine Stock Picks — Is YOUR portfolio ready?

The stock market doesn’t need a vaccine. It just needs positive news about the possibility of a vaccine. That’s what saw Monday. The positive interim phase 1 trial press release from biotech Moderna was a great trial run for investors. Today on Dumb Money Live, what news are we looking for? What stocks will benefit most? And more importantly, how are we are tming our entry points on the next news of a vaccine?